Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nilsson

Showing results (51-60 of 1,734) with videos related to

Pageof 174
Sort By:
Lakartidningen|November 25, 2011
[Systolic blood pressure of 130-135 is ideal for type 2 diabetes. The new meta-analyses provide guidance for the treatment]Peter M Nilsson
European Journal of Preventive Cardiology|December 5, 2019
Do we really need more new biomarkers for cardiovascular risk prediction?Peter M Nilsson
Acta Clinica Belgica|January 1, 1977
Synthetic activators of fibrinolysisI M Nilsson
The International Journal of Clinical and Experimental Hypnosis|January 1, 1990
The effect of subject expectations of "hypnosis" upon vividness of visual imageryK M Nilsson
Lakartidningen|May 31, 2013
[Causality can be shown with mendelian randomization. Cardiovascular risk relations tested with the method]Peter M Nilsson
Journal of Hypertension|October 3, 2015
Blood pressure control in type 2 diabetes over time - what can we learn from different trajectories?Peter M Nilsson
Experimental Gerontology|April 30, 2016
Blood pressure strategies and goals in elderly patients with hypertensionPeter M Nilsson
American Journal of Hypertension|October 7, 2017
Arterial Stiffness, the Metabolic Syndrome, and the BrainPeter M Nilsson
Journal of Hypertension|March 30, 2017
Hemodynamic effects by glucagon-like peptide-1 receptor analogues: what should be measured?Peter M Nilsson
Seminars in Hematology|April 1, 1988
Biochemical properties of Monoclate factor VIII:C antihemophilic factor (human) using monoclonal antibody to von Willebrand factor (VWF)I M Nilsson
Pageof 174

Showing results (51-60 of 1,734) with videos related to

Sort By:
Pageof 174
Lakartidningen|November 25, 2011
[Systolic blood pressure of 130-135 is ideal for type 2 diabetes. The new meta-analyses provide guidance for the treatment]Peter M Nilsson
European Journal of Preventive Cardiology|December 5, 2019
Do we really need more new biomarkers for cardiovascular risk prediction?Peter M Nilsson
Acta Clinica Belgica|January 1, 1977
Synthetic activators of fibrinolysisI M Nilsson
The International Journal of Clinical and Experimental Hypnosis|January 1, 1990
The effect of subject expectations of "hypnosis" upon vividness of visual imageryK M Nilsson
Lakartidningen|May 31, 2013
[Causality can be shown with mendelian randomization. Cardiovascular risk relations tested with the method]Peter M Nilsson
Journal of Hypertension|October 3, 2015
Blood pressure control in type 2 diabetes over time - what can we learn from different trajectories?Peter M Nilsson
Experimental Gerontology|April 30, 2016
Blood pressure strategies and goals in elderly patients with hypertensionPeter M Nilsson
American Journal of Hypertension|October 7, 2017
Arterial Stiffness, the Metabolic Syndrome, and the BrainPeter M Nilsson
Journal of Hypertension|March 30, 2017
Hemodynamic effects by glucagon-like peptide-1 receptor analogues: what should be measured?Peter M Nilsson
Seminars in Hematology|April 1, 1988
Biochemical properties of Monoclate factor VIII:C antihemophilic factor (human) using monoclonal antibody to von Willebrand factor (VWF)I M Nilsson
Pageof 174